The Latest in Non-Hodgkin Lymphoma

FDA’s Project Optimus aims to transform early cancer research

November 14, 2023

Care coordination, equity can eliminate disparities for nonwhite patients with DLBCL

December 8, 2019

Group proposes new grading systems for CRS, neurotoxicity

January 3, 2019

Combo bests standard care in younger CLL patients

December 12, 2018

Fludarabine deemed important for CD30.CAR T-cell therapy

December 11, 2018

Mutation confers resistance to venetoclax in CLL

December 7, 2018

Two-drug combo deemed ‘very promising’ for PMBCL

December 6, 2018

Regimen provides survival benefit in PTCL

December 4, 2018

New PCNSL guidelines emphasize importance of patient fitness

December 2, 2018

FDA approves biosimilar rituximab for NHL

November 29, 2018

EC approves mogamulizumab for MF, SS

November 28, 2018

ASH expands late-breaking abstract session

November 26, 2018

Biosimilar deemed equivalent to rituximab in FL

November 21, 2018

Elderly NHL patients have higher NRM after HSCT

November 20, 2018

Bortezomib may overcome resistance in WM

November 19, 2018